Jan 2025 – Michelle Nieman (shown) and her colleagues report A novel method for measurement of cardiovascular responses to lower body negative pressure in the awake instrumented rat.

Jan 2025 – The group describes a GenePHIT phase 2 study design: a double blind, placebo-controlled trial to assess efficacy, safety, and tolerability of Ab-1002 gene therapy In adults with heart failure.

Jan 2025 – Drew (Thompson lab) and co-authors report A divergent two-domain structure of the anti-Müllerian hormone prodomain.

Jan 2025 – Dr. Timme proposes a scheme for Reducing maladaptive behavior in neuropsychiatric disorders using network modification.

Jan 2025 – The group summarizes multiple approaches in Stronger together: a cross-SIG perspective on improving drug development.

Jan 2025 – Drs. Diego Perez-Tilve (pictured), Teresa Reyes, James Herman, Eric Wohleb, and Karthickeyan Chella Krishnan were each honored for consistently receiving sponsored research awards.